Shattuck Labs Inc at Piper Sandler Healthcare Conference Transcript
I think we'll get started here with our next presentation. I just want to thank everybody for joining us here on the final day of Piper Sandler's Annual Healthcare Conference. I'm Joe Catanzaro. I'm from the Piper biotech team. It's my pleasure to welcome Shattuck Labs and their CFO, Andrew Neill. And with that, I'll hand it over to Andrew.
Thank you, Joe. And thanks to the Piper team for the invitation to present this morning in New York. Nice to be back in person.
A quick bit of housekeeping before we get started. This presentation may contain forward-looking statements. Please see our SEC filings for more information.
Shattuck is pioneering the development of bi-functional fusion proteins as a potential therapeutic modality. Leveraging our expertise in protein engineering and design, we are developing two proprietary platform technologies.
First, our Agonist Redirected Checkpoint platform, of which our two lead clinical stage programs are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |